1-3 of 3
Junji Tsurutani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

KRAS and EGFR Amplifications Mediate Resistance to Rociletinib and Osimertinib in Acquired Afatinib-Resistant NSCLC Harboring Exon 19 Deletion/T790M in EGFR

Free
Kaori Nakatani, Toshimitsu Yamaoka, Motoi Ohba, Ken-Ichi Fujita, Satoru Arata, Sojiro Kusumoto, Iori Taki-Takemoto, Daisuke Kamei, Shinichi Iwai, Junji Tsurutani, Tohru Ohmori
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (1): 112–126.
https://doi.org/10.1158/1535-7163.MCT-18-0591
Published: 02 January 2019
View article titled, KRAS and EGFR Amplifications Mediate Resistance to Rociletinib and Osimertinib in Acquired Afatinib-Resistant NSCLC Harboring Exon 19 Deletion/T790M in EGFR
Open the PDF for KRAS and EGFR Amplifications Mediate Resistance to Rociletinib and Osimertinib in Acquired Afatinib-Resistant NSCLC Harboring Exon 19 Deletion/T790M in EGFR in another window
Includes: Supplementary data
Journal Articles

T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive Non–Small Cell Lung Cancer

Free
Satomi Watanabe, Takeshi Yoshida, Hisato Kawakami, Naoki Takegawa, Junko Tanizaki, Hidetoshi Hayashi, Masayuki Takeda, Kimio Yonesaka, Junji Tsurutani, Kazuhiko Nakagawa
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (11): 2563–2571.
https://doi.org/10.1158/1535-7163.MCT-17-0351
Published: 01 November 2017
View article titled, T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive Non–Small Cell Lung Cancer
Open the PDF for T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive Non–Small Cell Lung Cancer in another window
Journal Articles

The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells

Free
Seiji Doi, Hiroshi Soda, Mikio Oka, Junji Tsurutani, Takeshi Kitazaki, Yoichi Nakamura, Minoru Fukuda, Yasuaki Yamada, Shimeru Kamihira, Shigeru Kohno
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2004) 3 (11): 1397–1402.
https://doi.org/10.1158/1535-7163.1397.3.11
Published: 12 November 2004
View article titled, The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells
Open the PDF for The histone deacetylase inhibitor FR901228 induces caspase-dependent apoptosis via the mitochondrial pathway in small cell lung cancer cells in another window